Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis C

Free Subscription Articles published in Eur J Gastroenterol Hepatol Retrieve available abstracts of 51 articles: HTML format Text format

Single Articles

January 2012
1. FLOREANI A , Antoniazzi S, Mescoli C, Bergasa NV, et al
   Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C.
   Eur J Gastroenterol Hepatol. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
2. LIN YM , Sheu MJ, Kuo HT, Feng IC, et al
   The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy.
   Eur J Gastroenterol Hepatol. 2011;23:990-6.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
3. SARTORI M , Andorno S, Rossini A, Boldorini R, et al
   A case-control histological study on the effects of phlebotomy in patients with chronic hepatitis C.
   Eur J Gastroenterol Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. FLISIAK R , Halota W, Horban A, Juszczyk J, et al
   Prevalence and risk factors of HCV infection in Poland.
   Eur J Gastroenterol Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. HALFON P , Bourliere M, Ouzan D, Maor Y, et al
   A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.
   Eur J Gastroenterol Hepatol. 2011;23:931-935.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. YU JW , Sun LJ, Zhao YH, Kang P, et al
   The study of relationship between neutropenia and infection during treatment with peginterferon alpha and ribavirin for chronic hepatitis C.
   Eur J Gastroenterol Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. AMER ME , El-Sayed SZ, El-Kheir WA, Gabr H, et al
   Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells.
   Eur J Gastroenterol Hepatol. 2011;23:936-41.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
8. FLOREANI A , Cazzagon N, Boemo DG, Baldovin T, et al
   Female patients in fertile age with chronic hepatitis C, easy genotype, and persistently normal transaminases have a 100% chance to reach a sustained virological response.
   Eur J Gastroenterol Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. URBANEK P , Oltman M, Ivanovski L, Rehak V, et al
   Efficacy and safety of peginterferon alpha-2a (40 KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe.
   Eur J Gastroenterol Hepatol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. TAFAREL JR , Tolentino LH, Correa LM, Bonilha DR, et al
    Prediction of esophageal varices in hepatic cirrhosis by noninvasive markers.
    Eur J Gastroenterol Hepatol. 2011;23:754-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
11. MARINO Z , Carrion JA, Bedini JL, Crespo G, et al
    Evaluation of a portable hemoglobinometer (HemoCue) to control anemia in hepatitis C liver transplant recipients undergoing antiviral therapy.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
12. SHOEB D , Rowe IA, Freshwater D, Mutimer D, et al
    Response to antiviral therapy in patients with genotype 3 chronic hepatitis C: fibrosis but not race encourages relapse.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. FLOREANI A , Cazzagon N, Furlan P, Baldovin T, et al
    Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. MORIN T , Pariente A, Lahmek P
    Favorable outcome of acute occupational hepatitis C in healthcare workers: a multicenter French study on 23 cases.
    Eur J Gastroenterol Hepatol. 2011;23:515-20.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
15. CHEUNG KJ , Tilleman K, Deforce D, Colle I, et al
    Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. KIM RD , Fujikawa T, Mizuno S, Schwartz JJ, et al
    Adult post-transplant lymphoproliferative disease in the liver graft in patients with recurrent hepatitis C.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. HUSA P , Oltman M, Ivanovski L, Rehak V, et al
    Efficacy and safety of peginterferon alpha-2a (40 kD) plus ribavirin among patients with chronic hepatitis C and earlier treatment failure to interferon and ribavirin: an open-label study in central and Eastern Europe.
    Eur J Gastroenterol Hepatol. 2011;23:375-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
18. RIDRUEJO E
    Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life'.
    Eur J Gastroenterol Hepatol. 2011;23:195.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
19. SINGAL AK , Sagi S, Kuo YF, Weinman S, et al
    Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis.
    Eur J Gastroenterol Hepatol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. MURRAY MC , Barrios R, Zhang W, Hull M, et al
    Hepatitis C virus treatment rates and outcomes in HIV/hepatitis C virus co-infected individuals at an urban HIV clinic.
    Eur J Gastroenterol Hepatol. 2011;23:45-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. CHO HC , Jung HY, Sinn DH, Choi MS, et al
    Mortality after surgery in patients with liver cirrhosis: comparison of Child-Turcotte-Pugh, MELD and MELDNa score.
    Eur J Gastroenterol Hepatol. 2011;23:51-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
22. DEVITT EJ , Power KA, Lawless MW, Browne JA, et al
    Early proteomic analysis may allow noninvasive identification of hepatitis C response to treatment with pegylated interferon alpha-2b and ribavirin.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ORLENT H , Desombere I, Hansen B, Van Vlierberghe H, et al
    Baseline anti-NS4a antibodies in combination with on-treatment quantitative HCV-RNA reliably identifies nonresponders to pegylated interferon-ribavirin combination therapy after 4 weeks of treatment.
    Eur J Gastroenterol Hepatol. 2010;22:1443-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
24. ANDERSEN ES , Moessner BK, Christensen PB, Kjaer M, et al
    Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. LOWRY DJ , Ryan JD, Ullah N, Kelleher TB, et al
    Hepatitis C management: the challenge of dropout associated with male sex and injection drug use.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. PARIENTE A , Lahmek P, Duprat C, Denis J, et al
    Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life': a plea in favor of independent postmarketing evaluations.
    Eur J Gastroenterol Hepatol. 2010;22:1297-302.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
27. LINDENBURG CE , Lambers FA, Urbanus AT, Schinkel J, et al
    Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. DEVITT E , Lawless MW, Sadlier D, Browne JA, et al
    Early viral and peripheral blood mononuclear cell responses to pegylated interferon and ribavirin treatment: the first 24 h.
    Eur J Gastroenterol Hepatol. 2010;22:1211-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
29. AGGELOPOULOU-TIGA P , Dimitroulopoulos D, Kaligeros K, Koutsounas S, et al
    Pegylated interferon alfa-2b pen device and ribavirin treatment for patients with chronic hepatitis C: an evaluation of patient satisfaction.
    Eur J Gastroenterol Hepatol. 2010;22:1058-65.
    PubMed     Text format     Related articles   
    
    
    
    August 2010
30. PHILLIPS FH , Prebis M, Grumbeck C, Hale T, et al
    Effects of recognizing depression with a standardized questionnaire (CES-D) versus patient reporting of depression after a single-standardized question on the outcomes of treatment for hepatitis C with pegylated interferon-alpha-2b and ribavirin.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LANGE CM , von Wagner M, Bojunga J, Berg T, et al
    Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-alpha-2a and ribavirin.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. VAN VLERKEN LG , Van Soest H, Janssen MP, Boland GJ, et al
    Suboptimal endogenous erythropoietin response in chronic hepatitis C patients during ribavirin and PEG interferon treatment.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. EL-SHABRAWI MH , Omran S, Wageeh S, Isa M, et al
    (99m)Technetium-macroaggregated albumin perfusion lung scan versus contrast enhanced echocardiography in the diagnosis of the hepatopulmonary syndrome in children with chronic liver disease.
    Eur J Gastroenterol Hepatol. 2010;22:1006-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
34. CARNEIRO MV , Souza FF, Teixeira AC, Figueiredo JF, et al
    The H63D genetic variant of the HFE gene is independently associated with the virological response to interferon and ribavirin therapy in chronic hepatitis C.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. MUSALLAM KM , Sharara AI, Inati A, Taher AT, et al
    The role of liver iron in hepatitis C antiviral treatment.
    Eur J Gastroenterol Hepatol. 2010;22:769.
    PubMed     Text format     Related articles   
    
    
    
    May 2010
36. ZSCHIEDRICH S , Fischer R, Schmitt-Graff A, Blum H, et al
    Acute hepatitis after autologous stem cell transplantation and rapid progression to liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
37. LAHARIE D , Vergniol J, Bioulac-Sage P, Diris B, et al
    Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver.
    Eur J Gastroenterol Hepatol. 2010;22:487-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. ANASTASIOU J , Alisa A, Virtue S, Portmann B, et al
    Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
    Eur J Gastroenterol Hepatol. 2010;22:474-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
39. MELIN P , Chousterman M, Fontanges T, Ouzan D, et al
    Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. FAURIE P , Broussolle C, Zoulim F, Trepo C, et al
    Sarcoidosis and hepatitis C: clinical description of 11 cases.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. DESCHENES M , Bain VG, Lee SS, Sherman M, et al
    Identifying HCV genotype 1 patients at risk of relapse.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. GREBELY J , Knight E, Genoway KA, Viljoen M, et al
    Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.
    Eur J Gastroenterol Hepatol. 2010;22:270-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
43. CHEUNG KJ , Libbrecht L, Tilleman K, Deforce D, et al
    Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. DALGARD O , Bjoro K, Ring-Larsen H, Verbaan H, et al
    In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. GIANNOUSIS IP , Papatheodoridis GV, Deutsch MJ, Manolakopoulos SG, et al
    The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Eur J Gastroenterol Hepatol. 2010;22:172-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
46. EL-SHABRAWI MH , Mohsen NA, Sherif MM, El-Karaksy HM, et al
    Noninvasive assessment of hepatic fibrosis and necroinflammatory activity in Egyptian children with chronic hepatitis C virus infection using FibroTest and ActiTest.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. KAJIHARA M , Montagnese S, Khanna P, Amodio P, et al
    Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.
    Eur J Gastroenterol Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SHAFA S , Borum ML, Igiehon E
    A case of irreversible alopecia associated with ribavirin and peg-interferon therapy.
    Eur J Gastroenterol Hepatol. 2010;22:122-3.
    PubMed     Text format     Related articles   
    
    
    
    November 2009
49. OLMEZ OF , Gurel S, Yilmaz Y
    Plasma prohepcidin levels in patients with chronic viral hepatitis: relationship with liver fibrosis.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2009
50. KONDILI LA , Cuko L, Chionne P, Candido A, et al
    Hepatitis B, C and Delta virus infections in Albanian patients with chronic liver disease: evaluation of possible changes during the last 10 years.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2009
51. ZIOL M , Kettaneh A, Ganne-Carrie N, Barget N, et al
    Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
    Eur J Gastroenterol Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: